Correlation Between Tarsus Pharmaceuticals and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Spyre Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Spyre Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Spyre Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tarsus and Spyre is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Spyre Therapeutics
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.82 times more return on investment than Spyre Therapeutics. However, Tarsus Pharmaceuticals is 1.23 times less risky than Spyre Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.22 per unit of risk. If you would invest 3,900 in Tarsus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 740.00 from holding Tarsus Pharmaceuticals or generate 18.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Spyre Therapeutics
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Spyre Therapeutics |
Tarsus Pharmaceuticals and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Spyre Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.The idea behind Tarsus Pharmaceuticals and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Spyre Therapeutics vs. ZyVersa Therapeutics | Spyre Therapeutics vs. Sonnet Biotherapeutics Holdings | Spyre Therapeutics vs. Zura Bio Limited | Spyre Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |